Giovanni Vozzi – VJRegenMed

The role of 4D printing in regenerative medicine

Simon Ng — Wed, 19 Jan 2022 13:01:32 +0000

Giovanni Vozzi, PhD, University of Pisa, Pisa, Italy, discusses the advantages of 4D over 3D printing. Whilst 3D printing can create static scaffolds, the resulting structures may not capture the complexity of tissues in their physiological conditions, especially when the scaffolds are static as opposed to tissues react to various stimuli. 4D printing adds the dimension of time, where the product can change properties in response to external stimuli. This interview took place at the 6th World Congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS 2021).

Studying the gut microbiome with 3D modelling

Simon Ng — Wed, 19 Jan 2022 13:01:28 +0000

Giovanni Vozzi, PhD, University of Pisa, Pisa, Italy, comments on the relationship between the gut microbiota and the body. An in vitro model consisting of patient samples can observe changes in the microbiota from the stomach to the rectum, as well as changes in the metabolites produced and how it affects different tissues. Knowledge of the microbiota can subsequently optimize treatment strategies and the diets of patients to improve outcomes. This interview took place at the 6th World Congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS 2021).

How 4D printing techniques can progress

Simon Ng — Tue, 11 Jan 2022 17:26:20 +0000

Giovanni Vozzi, PhD, University of Pisa, Pisa, Italy, provides an overview of what needs to be done to advance the field of 4D printing. Prof. Vozzi highlights the need to realistically mimic tissues, especially in the context of the COVID-19 pandemic, where detailed lung tissue can be used to study the effects of the virus on the pulmonary system. Techniques in 3D printing also need to be optimized to accurately produce 4D scaffolds. This interview took place at the 6th World Congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS 2021).